India's coronavirus cases surpass 5 million mark




  • In US
  • 2020-09-16 04:13:25Z
  • By Reuters
India\
India\'s coronavirus cases surpass 5 million mark  

BENGALURU (Reuters) - India's coronavirus cases surged past 5 million on Wednesday with a single-day jump of 90,123 infections in the last 24 hours, data from the federal health ministry showed.

India is only the second country in the world to cross the grim milestone of 5 million cumulative cases, after the United States.

The death toll from COVID-19 is now at 82,066, the ministry said, with 1290 fatalities recorded in the last 24 hours.


(Reporting by Sachin Ravikumar; Editing by Shri Navaratnam)

COMMENTS

More Related News

Asia Today: India sees 83,000 new cases, but numbers falling
Asia Today: India sees 83,000 new cases, but numbers falling

India reported more than 83,000 new coronavirus cases on Wednesday, showing some decline after reaching a record a week earlier. The country has now confirmed more than 5.6 million cases. India is expected to become the world's worst-hit country within weeks, surpassing the United States, where nearly 6.9 million people have been infected by the virus.

Apple launches its online store in India
Apple launches its online store in India

For the first time in more than 20 years since Apple began its operations in India, the iPhone-maker has started selling its products directly to consumers in the world's second largest smartphone market. Apple launched its online store in India on Wednesday, which in addition to offering nearly the entire line-up of its products, also brings a range of services for the first time to consumers in the country. India is the 38th market for Apple where it has launched its online store.

India trials for Russia
India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks: exec
  • US
  • 2020-09-22 09:26:21Z

Dr Reddy's Laboratories Ltd could begin late-stage Indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the Indian drugmaker said on Tuesday. Indian trials of the Sputnik-V vaccine candidate, being developed by Russia's sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr. Reddy's, told Reuters. "We want to get to the first step - which is the commencement of the clinical trials by getting the necessary approvals from the Indian regulators - within the next few weeks," Sapra said.

India trials for Russia
India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks - executive

Dr Reddy's Laboratories Ltd could begin late-stage Indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the Indian drugmaker said on Tuesday. Indian trials of the Sputnik-V vaccine candidate, being developed by Russia's sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr. Reddy's, told Reuters. "We want to get to the first step - which is the commencement of the clinical trials by getting the necessary approvals from the Indian regulators - within the next few weeks," Sapra said.

India government bonds miss out on J.P. Morgan index inclusion
India government bonds miss out on J.P. Morgan index inclusion

J.P. Morgan has opted not to include India's government bonds in one of its flagship emerging market indexes after investors cited ongoing problems with capital controls, custody and settlement and other operational snags. India has one of the largest local currency government bond markets among emerging-market economies with over $800 billion in debt stock. With the added need to finance a COVID surge in debt issuance, the government had hoped its "Fully Accessible Route" (FAR) plan announced in March, that makes $115 billion of its bonds freely investible, would overcome these issues.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US